Hematology
From the Journals
Gaps in patient-provider survivorship communication persist
Over a recent 5-year period, there was little change in the percentages of patients who reported not having any detailed discussion with providers...
Conference Coverage
Noninvasive prenatal test may detect sickle cell disease
FORT LAUDERDALE, FLA. – Early data for a noninvasive prenatal test shows it could have the potential to accurately detect sickle cell disease.
Conference Coverage
Crizanlizumab shows posttreatment effect in sickle cell
FORT LAUDERDALE, FLA. – High-dose crizanlizumab may have a beneficial effect on vaso-occlusive events in sickle cell disease patients up to a year...
From the Journals
Osteoporotic fracture risk appears higher in adults with hemophilia
The risk of osteoporotic fractures following hemophilia increased with time and was significantly higher 5 years after the diagnosis.
Conference Coverage
No reduction in PE risk with vena cava filters after severe injury
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in...
From the Journals
AGA Clinical Practice Update: Coagulation in cirrhosis
Consider alternatives to blood products to mitigate the risk of worsening portal hypertension, infection, and immunologic complications.
Conference Coverage
Study: Why urban sickle cell patients quit hydroxyurea
Conference Coverage
Femoral head decompression relieves SCD hip pain
FORT LAUDERDALE, FLA. – Femoral head core decompression with bone marrow aspirate concentrate appears to reduce hip joint pain for sickle cell...
Conference Coverage
Orthopedic complications in sickle cell require prompt action
FORT LAUDERDALE, FLA. – Orthopedic crises are common in patients with sickle cell disease, and consultation with an orthopedic surgeon is...
Conference Coverage
Rozanolixizumab may offer new treatment paradigm for ITP
AMSTERDAM – “Data from this study indicate that we can achieve effective increases in platelet levels, we can observe decreasing IgG levels, and...
Conference Coverage
Insurance-related barriers impede L-glutamine access
FORT LAUDERDALE, FLA. – Just one in five patients prescribed L-glutamine were still taking the drug after 10 months, according to a new real-world...